Search for: "SANOFI-SYNTHELABO V. APOTEX, INC. "
Results 21 - 39
of 39
Sort by Relevance
|
Sort by Date
30 Nov 2009, 12:00 am
Budejovicky Budvar Narodni Podnik v Anheuser-Busch Inc (Class 46) (IPKat) EPO: Should green technology be subject to compulsory licensing? [read post]
2 Nov 2009, 1:20 pm
’s judgment for the Court in Apotex Inc. v. [read post]
29 Oct 2009, 11:11 am
Sanofi-Synthelabo, Inc. [read post]
13 May 2009, 11:44 pm
Cir. 2008); see also Sanofi-Synthelabo v. [read post]
23 Mar 2009, 7:34 am
Apotex, Inc. after the jump. [read post]
24 Dec 2008, 3:00 pm
Apotex, Inc (Managing Intellectual Property) [read post]
20 Dec 2008, 3:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Oleg Teterin seeks ‘tens of thousands of dollars’ for rights to use ;-) emoticon, a registered Russian trade mark (Techdirt) (RelatIP) (Ars Technica) (The IP Factor) (Out-Law) (Class 46) New UK copyright consultation: consultation issues include access to works, incentivising investment and creativity, recognising… [read post]
19 Dec 2008, 1:00 pm
$16.8 million for Alphapharm and Mylan: Takeda v Mylan (Patent Baristas) (Patent Docs) Boniva (Ibandronic acid) – US: Apotex challenges validity of Hoffmann-La Roche’s Boniva patent (Law360) Boniva (Ibandronic acid) – US: Orchid Chemicals & Pharmaceuticals and Orgenus Pharma seek declaratory judgment of invalidity and noninfringement in patent infringement suit brought by Hoffmann-La Roche over Boniva (Law360) Cardizem (Diltiazem) –… [read post]
16 Dec 2008, 5:16 am
Sanofi-Synthelabo, Sanofi-Synthelabo, Inc., and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership (collectively, Sanofi) brought suit under 35 U.S.C. [read post]
15 Dec 2008, 5:34 am
Sanofi-Synthelabo v. [read post]
28 Nov 2008, 12:49 pm
victories in fight for European BRCA patents (Holman's Biotech IP Blog) Europe: European Commission proposes strategy for dealing with rare diseases (Pharmacapsules @ Gowlings) US: Former House Ways and Means Economist claims 7-year data exclusive period is sufficient (Patent Docs) US: Medco predicts follow-on biologics regulatory pathway by 2011 (Patent Docs) US: Even after patent has expired, District Court has jurisdiction to set exclusivity date: In re Omeprazole Patent Litigation… [read post]
14 Nov 2008, 2:08 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Plavix (Clopidogrel) - Canada: Selection patents upheld by Supreme Court: Apotex v Sanofi-Synthelabo Canada (Jeremy de Beer)… [read post]
7 Nov 2008, 8:35 am
Sanofi-Synthelabo Canada Inc. [read post]
7 Nov 2008, 3:42 am
Sandoz, Inc (Patent Docs) (PATracer) Boniva (Ibandronic acid) – US: Hoffman La Roche files third patent infringement lawsuit against Orchid over generic Boniva (GenericsWeb) Carbatrol (Carbamazepine) – US: Federal Judge grants summary judgment of noninfringement to Corepharma in Carbatrol patent dispute with Shire Laboratories (Law360) Effexor (Venlafaxine) – US: Wyeth settles with fourth drug company, Anchen Pharmaceuticals, over generic Effexor (Law360)… [read post]
25 Jun 2007, 2:10 am
Apotex Inc. [read post]
19 Jun 2007, 9:45 pm
District Court for the Southern District of New York has issued a ruling in their favor in an infringement action against Apotex. [read post]
19 Jun 2007, 12:08 pm
Sanofi-Synthelabo v. [read post]
31 Aug 2006, 6:15 pm
Stein in Manhattan issued an injunction blocking the sale of generic Plavix ® (clopidogrel bisulfate) after a two-day hearing (Sanofi-Synthelabo v. [read post]
15 Aug 2006, 6:45 am
This is the court hearing the patent infringement suit, Sanofi-Synthelabo v. [read post]
